4.68
-0.1(-2.09%)
Currency In USD
| Previous Close | 4.78 |
| Open | 4.79 |
| Day High | 4.9 |
| Day Low | 4.62 |
| 52-Week High | 11.78 |
| 52-Week Low | 3.72 |
| Volume | 19,962 |
| Average Volume | 34,578 |
| Market Cap | 52.23M |
| PE | -1.62 |
| EPS | -2.89 |
| Moving Average 50 Days | 6.76 |
| Moving Average 200 Days | 6.76 |
| Change | -0.1 |
If you invested $1000 in Nutriband Inc. (NTRB) since IPO date, it would be worth $815.33 as of November 25, 2025 at a share price of $4.68. Whereas If you bought $1000 worth of Nutriband Inc. (NTRB) shares 3 years ago, it would be worth $1,200 as of November 25, 2025 at a share price of $4.68.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference
Newsfile
Yesterday at 12:00 PM GMT
Orlando, Florida--(Newsfile Corp. - November 24, 2025) - Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman and Co-Founder, Serguei Melnik will present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
GlobeNewswire Inc.
Oct 28, 2025 3:05 PM GMT
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received final meeting minutes from FDA and is incorporati
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
GlobeNewswire Inc.
Oct 28, 2025 11:00 AM GMT
Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received final meeting minutes from FDA and is incorporati